Health TrialsbyHealthPanel

The Hugo RAS Colorectal Collaborative

ConditionsColorectal SurgeryRobotic SurgeryColoRectal Cancer and Inflammatory Bowel Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The Hugo RAS Colorectal Collaborative (HRCC) is an international, multicenter dataset of patients undergoing colorectal surgery using the Hugo RAS system. The registry aims to analyze short and long-term outcomes to provide real-world evidence on the safety and effectiveness of the system.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients (age ≥ 18 years)

Scheduled to undergo any type of colorectal surgery (elective or emergent) where the Hugo RAS system is planned to be used

Willing and able to provide written informed consent

Disqualifiers

None

Trial population

Adult patients (≥18 years) undergoing any type of elective or emergent colorectal surgery using the Hugo RAS system. The population will be drawn from participating high-volume colorectal surgery centers across multiple countries. All eligible patients at these centers will be enrolled to minimize selection bias.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 1 trial group
Group A: Patients undergoing Hugo RAS colorectal surgery

Trial outcomes

Primary outcomes

1

Complications

Number of participants experiencing intraoperative complications, which will include the recording of robotic arm conflicts, system alarms (including red alarms), and any technical difficulties encountered.

Time frame
Intraoperatively
2

Rate of Postoperative Complications

Number and severity of postoperative complications assessed using the Clavien-Dindo classification system

Time frame
Postoperatively (30-day and 90-day)
3

Operative Time

Total duration in minutes of the surgical procedure measured to evaluate the efficacy of the Hugo RAS system.

Time frame
Intraoperatively
4

Blood loss

Measurement of blood loss during the surgical procedure. (ml)

Time frame
Intraoperatively.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: